Yecuris™, founded in Portland, United States, is a technology development company dedicated to advancing research tools for the scientific community. Their core mission is to provide innovative solutions that aid researchers in discovering cures for various diseases. Yecuris specializes in proprietary FRG® animal technologies, which have facilitated significant advancements in infectious disease, toxicology, and metabolism research. Their product offerings include FRG® KO Mice, fresh hepatocytes, and specialized reagents, catering to applications in gene editing, gene therapy, and viral hepatitis research.

Notable figures affiliated with Yecuris include leading scientists and researchers in the field of hepatic research. The company has attracted investments from prominent venture capital firms focused on biotech innovations. Key achievements of Yecuris include the development of next-generation tools that have been pivotal in breakthrough scientific studies. Their impact is evident in the enhanced accuracy and relevance of preclinical models, significantly contributing to the progress in medical research and therapeutic discoveries.